Manufacturer

Novartis Consumer Health

60 recalls in our database name Novartis Consumer Health as the manufacturing or recalling firm.

What the numbers show

Total: 60
Critical: 0
Severe: 1
Most recent: 2014-03-05

Of the 60 recalls from Novartis Consumer Health we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (2%) are Severe.

Which agencies issued them

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

51–60 of 60

LowFDA (Drugs)·D-573-2013·2013-06-12
Novartis Lamisil AT Cream Recalled for Illegible Lot and Expiration Dates
Novartis is recalling Lamisil AT Cream because the lot and expiration dates on the tubes may be illegible. The recall covers 12-gm and 30-gm tubes distributed nationwide, in Puerto Rico, and in Panama.
Product
Novartis Lamisil AT Cream, Terbinafine Hydrochloride Cream 1% Antifungal, Novartis Consumer Health, Inc., Parsippany, NJ. (a)12 gm (.42 oz), packaged with UPC code 300673998421 and NDC code: 0067-3998-42; (b) 12 gm (.42 oz), packaged with UPC code: 300673998124 and NDC c
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-575-2013·2013-06-12
Novartis Lamisil AT Cream Recalled for Illegible Lot and Expiration Dates
Novartis is recalling 219,600 tubes of Lamisil AT Cream because the lot and expiration dates may be illegible.
Product
Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1% antifungal), a) 12 g (.42 oz) Tube, NDC 0067-3999-12, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300673999121, (Vertical Pack) and b) packaged in a horizontal package12 gm (.42 oz) Tube, NDC 00
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-574-2013·2013-06-12
Novartis Recalls Target Up & Up Athlete's Foot Cream for Labeling Issues
Novartis is recalling Target Up & Up athlete's foot cream because the lot and expiration dates on the tubes may not be legible.
Product
Target Up & Up, athlete's foot cream, full prescription strength, terbinafine hydrochloride 1% antifungal, 30 g (1 oz), compare to active ingredient in Lamisil, NDC 0067-6382-30 & UPC code: 300676382302 (Novartis) Target NDC 1167-3401-04, Distributed by Target Corp., Minneapolis,
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-576-2013·2013-06-12
Novartis Recalls Lamisil AT Cream Due to Illegible Labeling
Novartis Consumer Health is recalling specific lots of Lamisil AT Cream because the lot and expiration dates on the tubes may be illegible.
Product
Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-420-2013·2013-05-29
Novartis Recalls Lamisil AT Antifungal Cream Due to Illegible Labeling
Novartis Consumer Health is recalling 3,828 tubes of Lamisil AT antifungal cream because the lot and expiration dates may be illegible.
Product
Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-209-2013·2013-03-27
Novartis Recalls 4 Way Nasal Spray Due to Illegible Labeling
Novartis Consumer Health is recalling 4 Way Nasal Spray because lot numbers and expiration dates may be illegible.
Product
4 WAY — 4 WAY (PHENYLEPHRINE HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-210-2013·2013-03-27
Novartis Recalls Nasal Spray Due to Illegible Lot and Expiration Dates
Novartis Consumer Health is recalling 4 way Nasal Decongestant Menthol Nasal Spray because lot numbers and expiration dates may be illegible.
Product
4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2087-05) b) 1-fl. oz. bottles (NDC 0067-2087-01), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-211-2013·2013-03-27
Novartis Recalls 4 Way Saline Moisturizing Mist Due to Labeling Errors
Novartis Consumer Health is recalling 4 Way Saline Moisturizing Mist bottles because lot numbers or expiration dates may be illegible or missing.
Product
4 way Saline Moisturizing Mist with Eucalyptol & Menthol, 1-fl. oz. bottles, OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-208-2013·2013-03-27
Novartis Recalls Nupercainal Ointment Due to Illegible Labeling
Novartis Consumer Health is recalling Nupercainal Ointment because lot numbers and expiration dates may be illegible or missing.
Product
Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-207-2013·2013-03-27
Novartis Recalls Myoflex Cream Due to Illegible Lot and Expiration Dates
Novartis Consumer Health is recalling Myoflex Pain Relieving Cream because lot numbers and expiration dates may be illegible. The recall covers 2-oz and 4-oz tubes distributed nationwide and in Panama.
Product
Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Category
Drug
Distribution
Distributed nationwide